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brane to remove water and solutes accumulated in patients with end-stage renal disease. The efficiency of osmosis during PD is crucial for technique and patient survival (3, 7, 20) . The high expression of AQP-1 (AQP1) in the endothelial cells lining peritoneal capillaries led to the early suggestion of a potential role for water channels in water transport generated during PD (6, 30) . The development of a mouse model of PD (18) and its application to Aqp1 mice indeed demonstrated that AQP1 accounts for ϳ50% of osmotic water transport when hypertonic glucose is used as osmotic agent (19) . Mouse models of PD have also contributed to the development and characterization of the first identified AQP1 agonist (31) , opening perspectives for the treatment of conditions associated with defective water handling.
During the last decades, radioiodinated ( 125 I) serum albumin (RISA) has been the most widely used tracer for intraperitoneal volume (IPV) measurement in rodent models of PD (22, 33) . However, the use of RISA is limited by the emission of ionizing radiation, imposing stringent safety regulations for storage, use, and waste handling. Fluorescent probes have been developed to overcome the limitations of radioactive agents and are increasingly used to assess various processes in vivo, including plasma volume changes in rodents (8, 11) . In the present study, we developed and validated a highly sensitive method using fluorescently labeled BSA tracers and fluorescence spectroscopy to monitor IPV and osmotic water transport across the peritoneal membrane. The relevance of this new technique to measure osmotic water transport and ultrafiltration (UF) was substantiated by using various osmotic solutions and mice lacking AQP1 and by comparing the accuracy of fluorescent tracers to direct volumetry and RISA.
METHODS

Animals.
Adult male SV129 mice (Charles River, Brussels, Belgium), aged 8 -14 wk, weighing 20 -30 g, were used to assess the kinetics of fluorescently labeled BSA and 125 I-human serum albumin and to evaluate the influence of the fluorescent tracer on transport and inflammation parameters in a mouse model of PD (18) . Gendermatched Aqp1 mouse littermates generated as previously described (15) , aged 8 -12 wk, were used to assess the influence of the water channel AQP1. All animals had access to a standard diet and tap water ad libitum. The experiments were conducted in accordance with the National Research Council Guide for the Care and Use of Laboratory Animals and the Animal Ethics Committee of the Université Catholique de Louvain Medical School.
Peritoneal transport studies and tissue sampling. Osmotic water transport across the peritoneum was investigated using a peritoneal equilibrium test, as previously described (18) . Briefly, following anesthesia with ketamine (100 mg/kg sc, Merial) and xylazine (10 mg/kg sc, Bayer), mice were laid in a supine position and the fur over the abdominal wall was shaved after desinfection with 70% alcohol. A silicon catheter (Venflon 22 G, 0.9-mm diameter, Terumo) was inserted percutaneously into the right lower quadrant of the peritoneal cavity. This catheter was used for the infusion and sampling of PD solution. Mice were intraperitoneally injected with 2.5 ml of glucosebased dialysate containing 100 g of albumin labeled with either a fluorescent dye (Alexa Fluor 488-, Alexa Fluor 555-, or Alexa Fluor 647-BSA; Molecular Probes, Invitrogen), FITC-albumin (Sigma-Aldrich), or RISA (Seralb-125, IBA, Cis-BioInternational). The instilled volume of 2.5 ml is between that obtained when scaling to body weight (ϳ0.7 ml) and to body surface area (ϳ10 ml), when considering a standard infusion of 2,000 ml in a 70-kg adult. Previous observations have shown that using a 2.5-ml instilled volume in mouse models of PD induced very similar glucose disappearance rates and net ultrafiltration across species, including humans (18) . The content of free 125 I in the spent dialysate was ϳ0.6% as checked by trichloroacetic acid (5% vol/vol) precipitation. A neutral pH dialysis solution (Physioneal 3.86%, pH ϳ7.4, Baxter Healthcare, Nivelles, Belgium) was used for tracer kinetics studies, while further experiments using Alexa Fluor 555-BSA were conducted with conventional dialysate [Dianeal 1.36 (344 mOsm/l) or 3.86% (483 mOsm/l), pH ϳ5.2, from Baxter Healthcare] or glucose 7% (657 mOsm/l). No intermediate sampling was performed during the assessment of the kinetics of the tracer mass to prevent the disappearance of the osmotic agent and tracer by multiple sampling (27) . Microsampling (10 l) was used at intermediate time points in other experiments to assess fluorescence. Before each sampling, the abdomen was gently agitated to facilitate fluid mixing. Instilled and recovered dialysate volumes were weighed on a precision balance (AG35, Mettler Toledo; margin of error during experiments is 0.1 mg). Dialysate recovery was performed at the end of the dwell, using syringes and preweighed safe-lock tubes; the remaining dialysate in the peritoneal cavity was collected using gauze tissue and weighed using the same technique. The fluid taken from the gauze tissue accounted for ϳ5% of total volume of the dialysate in both groups. Provided a 3.86% glucose dialysate density of 1.020 Ϯ 0.001 g/cm 3 in experimental conditions, the volume margin of error can be calculated as 0.1 l. Values rounded off to 1 l were used for both instilled and recovered volumes. These parameters were used to measure net UF by volumetry, as previously described (18) . Mean arterial blood pressure was recorded using a pressure transducer (Harvard Apparatus, Holliston, MA) connected to the right common carotid artery in anesthetized mice at baseline and during 2-h dwells with 3.86% glucose. The significant water removal and the resulting drop in blood pressure observed during PD had no effect on peritoneal water or solute transport in this mouse model (Fig. 1) . Samples from the visceral peritoneum were used for protein extraction, as previously described (18) .
Intraperitoneal pressure and external abdominal compression. Direct assessment of intraperitoneal pressure (IPP) was performed in anesthetized mice using a catheter that was inserted in the peritoneal cavity and connected to a pressure transducer. This transducer was validated against a water column and showed a very close correlation with the gold standard technique (Pearson r ϭ 0.9991, P Ͻ 0.0001); the interassay coefficient of variability using the transducer was 2.4%. The circuit was filled and, after zeroing at the level of the heart, left at atmospheric pressure. IPP vs. IPV curves were obtained with the instillation of variable volumes of dialysate in the peritoneal cavity (via a cock in the circuit) and assessment of IPP on the transducer. In a subset of experiments, IPP was modulated by external abdominal compression to assess the effect of IPP on transperitoneal tracer kinetics. IPP was raised using a neonatal sphygmomanometer (Philips, Eindhoven, The Netherlands) that was applied around the abdomen of mice and inflated to produce and external abdominal compression, a method that has previously been applied to rats (32) and adapted to mice. IPP was continuously monitored, as previously described, raised to 10 mmHg, and maintained constant for the dwell duration.
Fluorescence and radioactivity assessment. Relative fluorescence intensity in the dialysate, plasma, and peritoneal membrane extracts was assessed on a LS55 fluorescence spectrometer (PerkinElmer) using appropriate standards to prevent quenching and nonspecific interference after tracer extraction, as described (14) . Radioactivity in the dialysate, blood, and visceral peritoneum was assessed using a ␥-counter (Cobra II, Canberra-Packard, Downers Grove, IL) with statistics ensuring Ͻ1% Poisson error (i.e., at least 10,000 counts/ positive sample).
Quantification of Alexa Fluor 555-BSA by HPLC. Proteins were separated by reverse-phase HPLC on a GRACE Vydac C4 column (214TP54, 4.6 mm ϫ 25 cm) with an acetonitrile gradient in solvent A [2% (vol/vol) acetonitrile in 0.1% (vol/vol) trifluoroacetic acid]. Elution was performed with the following gradient program: 0 -90% solvent B [98% (vol/vol) acetonitrile in 0.085 trifluoroacetic acid] over 50 min at a flow rate of 500 l/min generated by a model 1260 Agilent solvent delivery system. Absorbance was monitored simultaneously at three wavelengths, namely, 214, 280, and 555 nm. Quantification of protein was performed by integration of the area under the curve for each absorbance peak.
Free fractions of the fluorescent dye in the recovered dialysate. Ultramicrofiltration was performed on the recovered dialysate of mice to confirm the absence of free fraction of the fluorescent dye. Amicon columns with a nominal cutoff of 30,000 Da (Millipore, Bedford, MA) were loaded with 3.86% Dianeal containing Alexa Fluor 555-BSA sampled at the end of a 2-h dwell in SV129 mice, and centrifuged at ϫ4,000 g for 10 min. Fluorescence was assessed on both the supernatant and the ultrafiltrate.
Nitrite/nitrate and albumin concentrations in the dialysate. The production of nitrite and nitrate in the dialysate was measured using a colorimetric assay (Cayman Chemical, Ann Arbor, MI). After 3-h incubation with nitrate reductase (670 mU/ml) and NADPH (160 mol/l) at room temperature, total nitrite concentration in the samples was measured by the Griess reaction at 540 nm (Benchmark Plus Microplate Reader, Bio-Rad, Hercules, CA). Albumin concentration in the dialysate at the end of the dwell was assessed using the Bradford assay (Bio-Rad Protein Assay, Bio-Rad).
Statistical analysis. Data are presented as means Ϯ SE. Comparisons between the means from different groups were performed using paired t-tests or one-way ANOVA, followed by Bonferroni's multiple comparison tests, as appropriate. The significance level is indicated in each figure.
RESULTS
Intraperitoneal kinetics of tracer albumin labeled with
125 I or fluorescent dyes. We first investigated the recovery of RISA and BSA labeled with fluorescent dyes (FITC, Alexa Fluor 488, Alexa Fluor 555, and Alexa Fluor 647) ( Fig. 2A) at the end of 2-h dwells with 3.86% glucose-based dialysate (pH 7.4) in a mouse model of PD (Table 1 ). The recovery of the mass of RISA, as well as all types of fluorescent BSA, was almost complete (ϳ99%), indicating negligible disappearance of the tracer from the peritoneal cavity in this model. This conclusion was supported by the minimal (ϳ1%) appearance of the instilled mass of RISA in plasma, with only traces (Ͻ0.1%) of RISA retrieved in the visceral peritoneum of exposed mice (data not shown).
According to the mass-balance principle, since the mass transfer of tracer albumin outside the peritoneal cavity is insignificant, IPV at time t can be calculated using the following equation:
where V 0 is the instilled volume of dialysate, and C 0 and C t , the concentrations of labeled albumin in the dialysate at time 0 and t, respectively. The IPV value derived from the tracer concentration at the end of the dwell was concordant with direct volumetric measurement of IPV, considered as the gold standard, for all tracers (Table 1 ).
Since the conventional dialysate solutions are acidic, we next evaluated the pH sensitivity of fluorescent albumin tracers in vitro. As expected, FITC-labeled BSA showed the most significant pH sensitivity whereas the fluorescence intensity of Alexa Fluor-labeled BSA is less (Alexa Fluor 488 and Alexa Fluor 647) or even not (Alexa Fluor 555) affected by acidic pH changes (ranging from 7.0 to 5.2) (Fig. 2B) . Accordingly, the linear relationship between fluorescence intensity and dialysate concentration of Alexa Fluor 555-BSA remained unaffected by changes in dialysate pH (Fig. 2C) .
Alexa Fluor 555-BSA to assess osmotic water transport during peritoneal dialysis. The pH insensitivity of Alexa Fluor 555-BSA, associated with its long wavelength, preventing potential interference from autofluorescence, justified the further characterization of Alexa Fluor 555-BSA as a tracer to assess IPV in a mouse model of PD using conventional dialysis solutions. The standard dialysis procedure (2-h dwell with 3.86% glucose-based dialysate) by itself did not affect the fluorescence intensity of the dye, and no free fractions were detected at the end of the dwells (data not shown). The addition of Alexa Fluor 555-BSA to the dialysate had no effect on transport [net ultrafiltration: 48.4 Ϯ 1.9 l/g vs. 47.8 Ϯ 1. We next confirmed that the instilled intraperitoneal mass of Alexa Fluor 555-BSA is completely recovered at the end of the procedure, independently of dwell duration and dialysate osmolality (Fig. 3A) . We used fluorescence spectroscopy (Fig. 3B) and HPLC (Fig. 3C) , two independent and highly sensitive techniques (lower limit of detection of Ͻ1% of the total injected mass), to confirm the virtual absence of Alexa Fluor 555-BSA in extracts from visceral peritoneum and plasma of exposed mice.
The validity of Alexa Fluor 555-BSA as an IPV tracer during PD was assessed by the direct comparison of the estimated values with volumetric IPV taken as the gold standard. The absolute values and kinetics of IPV estimated using Alexa Fluor 555-BSA were concordant to volumetric IPV (Fig.  3D) , irrespective of dialysate osmolality (Fig. 3E) . A close correlation between the estimated IPV and the volumetric IPV (Pearson coefficient, r ϭ 0.91, P Ͻ 0.001, n ϭ 23) was observed after dwells of different durations and using various concentrations of glucose (Fig. 3F) .
Since transperitoneal macromolecule absorption depends on intraperitoneal pressure (IPP) (32), we hypothesized that the very low IPP (Ͻ2 mmHg up to 10 ml of instilled dialysate) (Fig. 4A ) accounts for the lack of tracer disappearance from the peritoneal cavity in our mouse model of PD. We therefore evaluated the effect of modulating IPP (by external abdominal compression) on tracer kinetics. Increasing IPP from 0 to 10 mmHg resulted in a significant reduction of Alexa Fluor 555-BSA mass recovery in the dialysate at the end of 2-h dwells (from 1.00 Ϯ 0.02 to 0.85 Ϯ 0.02, respectively; P ϭ 0.001) (Fig. 4B) , and in a significant increase in the amount of Alexa Fluor 555-BSA detected in the plasma using fluorescence spectroscopy (Fig. 4C) . Similarly, mice exposed to elevated IPP had a higher Alexa Fluor 555-BSA content in their visceral peritoneum at the end of the dwell (data not shown). These observations support the hypothesis that low Values are means Ϯ SE. IPV, intraperitoneal volume. All exchanges were performed with 3.86% glucose-based dialysate during 120 min in SV129 mice. For intraperitoneal kinetics studies, n ϭ 6 mice/group for radioiodinated 125 I human serum albumin and Alexa Fluor 555-labeled BSA and n ϭ 3 for FITC-, Alexa Fluor 488-, and Alexa Fluor 647-labeled BSA. 1, Extinction coefficient of the reactive dye at emission maximum in cm/M. 2, IPV120, IPV at 120 min of the dwell measured volumetrically or estimated from tracer dilution.
IPP accounts for the negligible disappearance of macromolecular tracers in our mouse model of PD.
Alexa Fluor 555-BSA to assess IPV kinetics: applications to mouse models of PD. Having established the validity and accuracy of Alexa Fluor 555-BSA to assess IPV kinetics, we next assessed the usefulness of the fluorescent indicator dilution technique to detect changes in osmotic water transport over time. Modulation of water transport across the mouse peritoneum was achieved in two independent models, first by varying the transperitoneal osmotic gradient (Fig. 5) , and second by genetic deletion of the water channel AQP1 (Fig. 6) .
Increasing glucose concentration in the dialysate from 1.36 to 3.86 and further to 7% was reflected by a faster movement of water across the peritoneum and increased final IPV (Fig.  5A, Table 2 ). Both the osmotic water transport over 120 min, estimated by the area under the IPV curves (Fig. 5B) and the AQP1-mediated water transport, corresponding to the UF rate during the first 30 min of the dwell (Fig. 5C) , showed a linear relationship with dialysate osmolality (Pearson coefficient, r ϭ 0.98, P Ͻ 0.001; and 0.94, P Ͻ 0.001, respectively; n ϭ 14 for both measures).
Mice lacking AQP1 represent a useful model to assess the ultrasmall pore component of water transport during PD. Previous studies based on RISA have demonstrated that the lack of AQP1 is reflected by a significant decrease in the initial UF rate and a loss of ϳ50% of the UF capacity during a hypertonic dwell (19, 30) . We first showed that the tracer mass of Alexa Fluor 555-BSA was constant during the 120-min dwell in Aqp1 mice (mean tracer recovery 99.0 Ϯ 2.0%, n ϭ 12). There was a close correspondence between the IPV at the end of the dwell estimated from the tracer dilution vs. that obtained by volumetry ( Table 2) . Comparison of the osmotic water transport parameters assessed by using Alexa Fluor 555-BSA vs. those obtained with RISA in the seminal work in Aqp1 mice (19) demonstrated that both techniques yield highly correlated values of IPV (Pearson coefficient, r ϭ 0.98, P Ͻ 0.0001) (Fig. 6, A and B, Table 2 ). In agreement with the role of AQP1 in mediating water transport during PD, the use of Alexa Fluor 555-BSA as a tracer yielded the same reduction in net UF, area under the IPV curve, and initial UF rate than RISA in the Aqp1Ϫ/Ϫ mice compared with their wild-type littermates (Fig. 6C) . . No significant amount of tracer is detected using fluorescence spectroscopy on the plasma of exposed mice, with a lower limit of detection of 1 g/ml (1% of the injected tracer mass). C: HPLC and absorbance at 555 nm of control plasma from SV129 mice spiked with various concentrations of Alexa Fluor 555-BSA (blue lines) and after intraperitoneal exposure to the fluorescent tracer during a 120-min dwell (P120, red line). The peak of absorbance at 555 nm after an elution time of 34.6 min corresponding to Alexa Fluor 555-BSA in standards is negligible in the plasma of exposed mice. D: intraperitoneal volume (IPV) estimated with Alexa Fluor 555-BSA is concordant with direct volumetry at each time point during PD with 3.86% glucose-based dialysate. E: estimated and volumetrically measured IPV are in good agreement at the end of 2-h dwells performed with 1.36, 3.86, and 7% glucose-based dialysates. F: IPV estimated using the dilution of Alexa Fluor 555-BSA closely correlate with the data obtained by volumetry (Pearson r ϭ 0.91, P Ͻ 0.0001). Values are means Ϯ SE; n ϭ 3 for 30-, 60-, and 90-min dwells with 3.86% glucose, n ϭ 6 for 120-min dwells with 3.86% glucose, and n ϭ 4 for 120-min dwells with 1.36 and 7% glucose.
DISCUSSION
Fluorescent dyes are increasingly used in biomedical research to avoid limitations and safety risks of radiolabeled tracers (8, 11, 14) . In this study, we used well-established models of PD to demonstrate that Alexa Fluor 555-BSA is an easy-to-use, neutral, and accurate IPV tracer that allows the study of osmotic water transport in vivo.
Alexa Fluor dyes are a new family of bright, photostable, and water-soluble fluorophores obtained by sulfonation of rhodamine or coumarin molecules (2, 21) . Sulfonation makes Alexa Fluor molecules negatively charged and hydrophilic, contributing to the stability of these dyes, and to their strong pH insensitivity, allowing their efficient use in a broad range of pH (21) . Among Alexa Fluor dyes, Alexa Fluor 555 was shown Fig. 4 . Influence of intraperitoneal pressure (IPP) on tracer kinetics in the mouse model of PD. A: IPP vs. IPV curves in SV129 mice. IPP remains Յ2 mmHg for IPV Ͻ10 ml, then increases in an exponential way for larger IPV values; n ϭ 5 adult male SV129 mice. Isotonic saline was progressively instilled into the peritoneal cavity to increase IPV from baseline to 15 ml. B: effect of external abdominal compression and elevated IPP on the recovery of Alexa Fluor 555-BSA in the drained dialysate. Increasing IPP from 0 to 8 and 10 mmHg significantly decreases tracer mass recovery at the end of the dwell in the peritoneal cavity of mice exposed to Alexa Fluor 555-BSA (from 100 to 92 Ϯ 2 and 85 Ϯ 2%, respectively; P ϭ 0.001). C: effect of external abdominal compression and elevated IPP on tracer appearance in the plasma. Fluorescence excitation spectrum of plasma from mice exposed to a 2-h PD with 100 g of Alexa Fluor 555-BSA shows a progressive rise in the amount of Alexa Fluor 555-BSA detected in the plasma when IPP is increased from 0 to 8 and 10 mmHg (green, orange, and red lines, respectively). Results are compared with the fluorescence excitation spectrum of plasma from control mice spiked with different concentrations (0 -5 g/ml, grey dotted lines) of Alexa Fluor 555-BSA. Dwells were performed with 3.86% glucose-based dialysate for 2 h; n ϭ 4 -5 in each group. Fig. 5 . Alexa Fluor 555-BSA to assess IPV kinetics: effect of the osmotic gradient. A: increasing glucose concentration from 1.36 to 3.86 and 7% in dialysate significantly enhances osmotic water transport during PD, as shown by IPV kinetics. B: enhanced osmotic water transport is reflected by the area under the net UF curves (39 Ϯ 3, 99 Ϯ 5, and 163 Ϯ 3 ml/min for 1.36, 3.86, and 7% glucose, respectively). Inset: linear relationship between osmotic water transport estimated using the area under the net UF curve and dialysate osmolality. C: increasing dialysate osmolality drives a faster UF rate during the first 30 min of the dwell (3.5 Ϯ 0.6, 23.1 Ϯ 1.1 and 31.9 Ϯ 0.5 l/min for 1.36, 3.86, and 7% glucose, respectively), when the contribution of aquaporin-1 to transcapillary UF is maximal. All exchanges were performed using 2.5 ml of 1.36 (green), 3.86 (blue), or 7% (red) glucose-based dialysate. Values are means Ϯ SE; n ϭ 4 for 1.36 and 7%, and n ϭ 6 for 3.86% glucose. ***P Ͻ 0.001 vs. 1.36% glucose, and ### p Ͻ 0.001 versus 3.86% glucose.
to be the more pH insensitive in the studied range of pH (5.2-7.4), in agreement with previous observations in which red-orange fluorescent dyes have the lowest pK a values, as low as 2.7 (4). During PD with conventional solutions, rapid changes in intraperitoneal pH occur, as a result of transperitoneal buffers and gas transport (12) . Covalent conjugation of Alexa Fluor dyes to specific proteins such as BSA (2) prevents the appearance of free fractions, limiting the risk of free dye absorption. The addition of tracer concentrations of fluorescent albumin to the PD solution had no effect on parameters of transport and inflammation during PD. The validity and accuracy of Alexa Fluor 555-BSA to assess osmotic water changes in vivo are demonstrated by the close correlation between IPV based on the dilution of the fluorescent tracer Alexa Fluor 555-BSA and IPV measured by volumetry, considered as the gold standard technique (27) . The use of Alexa Fluor 555-BSA as an indicator of osmotic water transport is further validated by the similar IPV values over time obtained with Alexa Fluor 555-BSA and RISA in Aqp1 mice, which represent a critical tool to assess osmotic water transport in rodent models of PD. The serial assessment of IPV over time in the same animal yielded IPV curves exactly similar to those previously obtained using the RISA technique (19) . Similar values of osmotic water transport and initial UF rates, two parameters that are directly linked to the nature of the dialysate and the availability of AQP1 water channels, respectively, were also obtained using either Alexa Fluor 555-BSA or RISA (19, 31) .
Application of a macromolecular IPV tracer to assess osmotic water changes in mouse models of PD warrants a careful evaluation of the kinetics of the intraperitoneal mass of the tracer during the dwell. In the present model, the intraperitoneal mass of fluorescent albumins used as IPV tracers is constant throughout all experiments, independently of the fluorescent dye, dwell time, and dialysate osmolality. Minimal disappearance of Alexa Fluor 555-BSA from the peritoneal cavity is corroborated by the lack of significant tracer detection in plasma or visceral peritoneum of exposed mice based on fluorescence spectroscopy and HPLC, which are both highly sensitive (detection limit ϳ1 g/ml) whereas HPLC allows to rule out any artifact due to fluorescence. The lack of disappearance of RISA from the peritoneal cavity in this mouse model confirms these results. The data presented here suggest that the very low IPP in basal conditions accounts for the lack of disappearance of fluorescent albumin tracers from the peritoneal cavity. Conversely, increasing IPP by external abdom- inal compression results in a significant reduction in tracer mass recovery in the dialysate, and a parallel increase in tracer appearance in the plasma and in the peritoneal membrane. In other rodent models of PD, disappearance of the macromolecular IPV tracer (RISA, dextrans, or autologous hemoglobin) from the peritoneal cavity (up to 10 -30%) can occur as a result of an uptake into lymphatic vessels (mainly subdiaphragmatic) and interstitial tissues lining the peritoneal cavity (10, 34) . In those models, transperitoneal transport of macromolecules from dialysate to plasma indeed depends on the nature of the tracer (5, 17) and, more importantly, on IPP, which directly determines tracer disappearance (9, 23, 32, 35) . When present, tracer disappearance requires correcting equations to avoid overestimation of IPV, and to accurately assess IPV over time (5, 16, 22) . We speculate that differences in abdominal wall compliance among species, in the type of anesthesia and related effects on diaphragmatic contraction, and in the use or not of mechanical ventilation, influence IPP and account, at least partly, for the variability in macromolecular tracer disappearance in rodent models of PD (13, 24 -26) . Careful evaluation of tracer mass kinetics is therefore a prerequisite for the application of indicator dilution techniques assessing IPV in animal models of PD. Altogether, these data support the appropriateness of fluorescently labeled macromolecules, and more specifically Alexa Fluor 555-BSA, as alternative IPV tracers to RISA to accurately assess IPV in mouse models of PD, decipher the molecular mechanisms of water transport, and evaluate interventions modifying water transport in vivo. Further investigations are required to investigate the potential use of fluorescently labeled macromolecules to assess IPV over time in PD patients.
